{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:15:37Z","timestamp":1780730137335,"version":"3.54.1"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":271,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007949","name":"Swedish Rheumatism Association","doi-asserted-by":"publisher","award":["R-664091"],"award-info":[{"award-number":["R-664091"]}],"id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"publisher","award":["ALFSKANE-446501"],"award-info":[{"award-number":["ALFSKANE-446501"]}],"id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To identify predictors of GCA in patients with PMR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with PMR were identified among participants in two population-based health surveys. Those with a registered diagnosis indicating PMR in national and regional registers (the latter including primary care) were included. Medical records from hospitals and primary care were systematically reviewed. PMR diagnoses were verified by a rheumatologist in an independent review. Potential predictors were examined using logistic regression analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 1508 medical records, 1030 had sufficient data available. PMR diagnoses were verified in 626 patients (61%). GCA was diagnosed within 1\u2009month of PMR diagnosis in 37 patients and at a later time point in 20 patients. Female patients were more likely to develop GCA at PMR diagnosis or later [odds ratio (OR) 2.38 (95% CI 1.23, 4.61)]. Higher ESR and CRP levels were also associated with GCA. A lower risk for GCA was seen in those presenting with pain\/stiffness in the hip [OR 0.51 (95% CI 0.28, 0.92)].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this large cohort of patients with verified PMR, GCA was diagnosed in a limited subset (9%) and was more common in females. A lower risk for GCA was seen in patients with pain\/stiffness in the hip at onset of PMR, suggesting that prominent musculoskeletal symptoms and cranial arteritis represent different parts of the GCA\u2013PMR spectrum.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rap\/rkaf112","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T12:00:41Z","timestamp":1758888041000},"source":"Crossref","is-referenced-by-count":0,"title":["Predictors of giant cell arteritis in patients with polymyalgia rheumatica in southern Sweden\u2014a retrospective study"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6613-7436","authenticated-orcid":false,"given":"Charlotta","family":"Fors","sequence":"first","affiliation":[{"name":"Rheumatology, Department of Clinical Sciences, Lund University , Malm\u00f6,","place":["Sweden"]},{"name":"Department of Rheumatology, Sk\u00e5ne University Hospital , Malm\u00f6,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Bergstr\u00f6m","sequence":"additional","affiliation":[{"name":"Rheumatology, Department of Clinical Sciences, Lund University , Malm\u00f6,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7169-6936","authenticated-orcid":false,"given":"Aladdin J","family":"Mohammad","sequence":"additional","affiliation":[{"name":"Rheumatology, Department of Clinical Sciences, Lund University , Lund,","place":["Sweden"]},{"name":"Department of Rheumatology, Sk\u00e5ne University Hospital , Lund,","place":["Sweden"]},{"name":"Department of Medicine, University of Cambridge , Cambridge,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3805-2290","authenticated-orcid":false,"given":"Carl","family":"Turesson","sequence":"additional","affiliation":[{"name":"Rheumatology, Department of Clinical Sciences, Lund University , Malm\u00f6,","place":["Sweden"]},{"name":"Department of Rheumatology, Sk\u00e5ne University Hospital , Malm\u00f6,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"2025102421420803300_rkaf112-B1","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1001\/jama.2020.10155","article-title":"Polymyalgia rheumatica and giant cell arteritis","volume":"324","author":"Buttgereit","year":"2020","journal-title":"JAMA"},{"key":"2025102421420803300_rkaf112-B2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/bmj.39514.653588.80","article-title":"Polymyalgia rheumatica","volume":"336","author":"Michet","year":"2008","journal-title":"BMJ"},{"key":"2025102421420803300_rkaf112-B3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7326\/0003-4819-123-3-199508010-00006","article-title":"The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern","volume":"123","author":"Salvarani","year":"1995","journal-title":"Ann Intern Med"},{"key":"2025102421420803300_rkaf112-B4","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.semarthrit.2020.07.005","article-title":"Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: a systematic literature review","volume":"50","author":"Sharma","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2025102421420803300_rkaf112-B5","doi-asserted-by":"crossref","first-page":"103415","DOI":"10.1016\/j.autrev.2023.103415","article-title":"Subclinical giant cell arteritis in polymyalgia rheumatica: concurrent conditions or a common spectrum of inflammatory diseases?","volume":"23","author":"Salvarani","year":"2024","journal-title":"Autoimmun Rev"},{"key":"2025102421420803300_rkaf112-B6","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41584-023-00976-8","article-title":"Disease stratification in GCA and PMR: state of the art and future perspectives","volume":"19","author":"Tomelleri","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"2025102421420803300_rkaf112-B7","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2013.161","article-title":"Immune mechanisms in medium and large-vessel vasculitis","volume":"9","author":"Weyand","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"2025102421420803300_rkaf112-B8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/joim.13525","article-title":"An update on polymyalgia rheumatica","volume":"292","author":"Lundberg","year":"2022","journal-title":"J Intern Med"},{"key":"2025102421420803300_rkaf112-B9","doi-asserted-by":"crossref","first-page":"152017","DOI":"10.1016\/j.semarthrit.2022.152017","article-title":"Subclinical giant cell arteritis in new onset polymyalgia rheumatica: a systematic review and meta-analysis of individual patient data","volume":"55","author":"Hemmig","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"2025102421420803300_rkaf112-B10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/ard-2023-224768","article-title":"Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica","volume":"83","author":"De Miguel","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2025102421420803300_rkaf112-B11","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia rheumatica and giant cell arteritis: a systematic review","volume":"315","author":"Buttgereit","year":"2016","journal-title":"JAMA"},{"key":"2025102421420803300_rkaf112-B12","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s40266-019-00705-5","article-title":"Pathogenesis, diagnosis and management of polymyalgia rheumatica","volume":"36","author":"Camellino","year":"2019","journal-title":"Drugs Aging"},{"key":"2025102421420803300_rkaf112-B13","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/art.42325","article-title":"2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis","volume":"74","author":"Ponte","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2025102421420803300_rkaf112-B14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/ard.38.5.434","article-title":"An evaluation of criteria for polymyalgia rheumatica","volume":"38","author":"Bird","year":"1979","journal-title":"Ann Rheum Dis"},{"key":"2025102421420803300_rkaf112-B15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/ard.40.1.1","article-title":"Prognosis and management of polymyalgia rheumatica","volume":"40","author":"Jones","year":"1981","journal-title":"Ann Rheum Dis"},{"key":"2025102421420803300_rkaf112-B16","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-97-5-672","article-title":"Polymyalgia rheumatica: a 10-year epidemiologic and clinical study","volume":"97","author":"Chuang","year":"1982","journal-title":"Ann Intern Med"},{"key":"2025102421420803300_rkaf112-B17","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0049-0172(84)90012-X","article-title":"Long-term follow-up of polymyalgia rheumatica: evidence for synovitis","volume":"13","author":"Healey","year":"1984","journal-title":"Semin Arthritis Rheum"},{"key":"2025102421420803300_rkaf112-B18","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","article-title":"2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"71","author":"Dasgupta","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2025102421420803300_rkaf112-B19","doi-asserted-by":"crossref","first-page":"rkz033","DOI":"10.1093\/rap\/rkz033","article-title":"Validity of polymyalgia rheumatica diagnoses and classification criteria in primary health care","volume":"3","author":"Fors","year":"2019","journal-title":"Rheumatol Adv Pract"},{"key":"2025102421420803300_rkaf112-B20","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"2025102421420803300_rkaf112-B21","first-page":"506","article-title":"The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease","volume":"56","author":"Dejaco","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2025102421420803300_rkaf112-B22","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1093\/rheumatology\/keac713","article-title":"An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologists","volume":"62","author":"Donskov","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2025102421420803300_rkaf112-B23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2025102421420803300_rkaf112-B24","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00008469-200112000-00003","article-title":"The Malm\u00f6 Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants","volume":"10","author":"Manjer","year":"2001","journal-title":"Eur J Cancer Prev"},{"key":"2025102421420803300_rkaf112-B25","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1365-2796.1996.483819000.x","article-title":"Cardiovascular risk groups and mortality in an urban Swedish male population: the Malm\u00f6 Preventive Project","volume":"239","author":"Berglund","year":"1996","journal-title":"J Intern Med"},{"key":"2025102421420803300_rkaf112-B26","author":"National Board of Health, Sweden"},{"key":"2025102421420803300_rkaf112-B27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/1403494819868042","article-title":"The value of the Sk\u00e5ne Health-care Register: prospectively collected individual-level data for population-based studies","volume":"48","author":"L\u00f6fvendahl","year":"2020","journal-title":"Scand J Public Health"},{"key":"2025102421420803300_rkaf112-B28","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1136\/ard-2022-223480","article-title":"2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis","volume":"81","author":"Ponte","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2025102421420803300_rkaf112-B29","doi-asserted-by":"crossref","first-page":"1142723","DOI":"10.3389\/fimmu.2023.1142723","article-title":"Sex and gender influence on immunity and autoimmunity","volume":"14","author":"Lahita","year":"2023","journal-title":"Front Immunol"},{"key":"2025102421420803300_rkaf112-B30","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/art.27425","article-title":"Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955\u20132007","volume":"62","author":"Myasoedova","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2025102421420803300_rkaf112-B31","first-page":"2547","article-title":"Impact of gender and age at onset on Sj\u00f6gren\u2019s syndrome presentation and outcome: state of the art","volume":"41","author":"Fulvio","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"2025102421420803300_rkaf112-B32","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/ard.2005.039404","article-title":"Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis","volume":"65","author":"Larsson","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2025102421420803300_rkaf112-B33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/rheumatology\/keu331","article-title":"Body mass index and the risk of giant cell arteritis: results from a prospective study","volume":"54","author":"Jakobsson","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"2025102421420803300_rkaf112-B34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13075-024-03273-1","article-title":"Apolipoproteins and the risk of giant cell arteritis\u2014a nested case\u2013control study","volume":"26","author":"Wadstr\u00f6m","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"2025102421420803300_rkaf112-B35","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1093\/rheumatology\/keaa080","article-title":"Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis","volume":"59","author":"Wadstr\u00f6m","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2025102421420803300_rkaf112-B36","first-page":"1750","article-title":"Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica","volume":"25","author":"Gonz\u00e1lez-Gay","year":"1998","journal-title":"J Rheumatol"},{"key":"2025102421420803300_rkaf112-B37","first-page":"1326","article-title":"The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study","volume":"26","author":"Gonz\u00e1lez-Gay","year":"1999","journal-title":"J Rheumatol"},{"key":"2025102421420803300_rkaf112-B38","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.semarthrit.2018.05.007","article-title":"Predictors of positive 18F-FDG PET\/CT-scan for large vessel vasculitis in patients with persistent polymyalgia rheumatica","volume":"48","author":"Prieto-Pe\u00f1a","year":"2019","journal-title":"Semin Arthritis Rheum"}],"container-title":["Rheumatology Advances in Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumap\/advance-article-pdf\/doi\/10.1093\/rap\/rkaf112\/64425906\/rkaf112.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/9\/4\/rkaf112\/64425906\/rkaf112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/9\/4\/rkaf112\/64425906\/rkaf112.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T01:42:19Z","timestamp":1761356539000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumap\/article\/doi\/10.1093\/rap\/rkaf112\/8267721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,9,13]]}},"URL":"https:\/\/doi.org\/10.1093\/rap\/rkaf112","relation":{},"ISSN":["2514-1775"],"issn-type":[{"value":"2514-1775","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"rkaf112"}}